Apoquel (oclacitinib maleate) for Dogs is a breakthrough in managing allergic itch swiftly and effectively. As the #1 prescribed oral treatment for allergic itch, it delivers rapid relief within 24 hours and begins to control itching in just 4 hours, comparable to oral steroids but without their potential side effects. This synthetic Janus Kinase (JAK) inhibitor is designed to specifically target and manage pruritus associated with allergic dermatitis and atopic dermatitis in dogs aged 12 months and older. Apoquel not only controls inflammation but also reduces clinical signs, making it an optimal choice for flea allergies, food allergies, atopic dermatitis, and contact allergies.
Apoquel contains oclacitinib maleate as an active ingredient that works by targeting and inhibiting Janus Kinase (JAK) enzymes involved in the signaling pathway of itch and inflammation. By blocking these enzymes, Apoquel effectively reduces pruritus (itch) associated with allergic dermatitis and atopic dermatitis in dogs. This targeted approach helps control itching rapidly, within 24 hours, and provides ongoing relief without the potential side effects commonly associated with steroids.
